T. Rowe Price Associates
ASTH icon

T. Rowe Price Associates’s Astrana Health ASTH Stock Holding History

T. Rowe Price Associates’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Buy
62,163
+12,745
+26% +$459K ﹤0.01% 1833
2026
Q1 		$1.21M Buy
49,418
+7,160
+17% +$170K ﹤0.01% 2058
2025
Q4 		$1.05M Buy
42,258
+1,562
+4% +$41.5K ﹤0.01% 2069
2025
Q3 		$1.15M Buy
40,696
+5,113
+14% +$139K ﹤0.01% 1997
2025
Q2 		$886K Sell
35,583
-515
-1% -$14.5K ﹤0.01% 2040
2025
Q1 		$1.12M Buy
36,098
+3,143
+10% +$105K ﹤0.01% 1898
2024
Q4 		$1.04M Sell
32,955
-706
-2% -$33.5K ﹤0.01% 1947
2024
Q3 		$1.95M Buy
33,661
+986
+3% +$48.4K ﹤0.01% 1649
2024
Q2 		$1.33M Buy
32,675
+1,305
+4% +$51.8K ﹤0.01% 1765
2024
Q1 		$1.32M Buy
31,370
+1,587
+5% +$61.9K ﹤0.01% 1769
2023
Q4 		$1.14M Buy
29,783
+1,086
+4% +$36.2K ﹤0.01% 1804
2023
Q3 		$886K Buy
28,697
+1,720
+6% +$59.4K ﹤0.01% 1854
2023
Q2 		$853K Buy
26,977
+1,182
+5% +$40.5K ﹤0.01% 1883
2023
Q1 		$941K Buy
25,795
+968
+4% +$33.9K ﹤0.01% 1820
2022
Q4 		$735K Buy
24,827
+3,248
+15% +$104K ﹤0.01% 1945
2022
Q3 		$842K Buy
21,579
+3,731
+21% +$171K ﹤0.01% 1845
2022
Q2 		$689K Sell
17,848
-438
-2% -$16.7K ﹤0.01% 2073
2022
Q1 		$886K Buy
18,286
+3,166
+21% +$163K ﹤0.01% 2062
2021
Q4 		$1.11M Buy
15,120
+1,888
+14% +$155K ﹤0.01% 1981
2021
Q3 		$1.21M Buy
+13,232
New +$1.13M ﹤0.01% 1960

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates's ASTH Position: Q2 2026 in Review

T. Rowe Price Associates increased its Astrana Health (ASTH) stake by 26% in Q2 2026, buying an estimated $459K and bringing the position to 62,163 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

T. Rowe Price Associates first reported a position in ASTH in Q3 2021 and has held it in 20 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • T. Rowe Price Associates held 62,163 shares of Astrana Health worth $2.88M as of Q2 2026.
  • T. Rowe Price Associates bought 12,745 Astrana Health shares in Q2 2026, an estimated $459K.
  • Astrana Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1833 holding.
  • T. Rowe Price Associates first reported a position in Astrana Health in Q3 2021 and has held it in 20 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.